| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | L49V5G013I |
| InChI Key | LZLBRISQTJVZNP-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C25H35NO5S |
| Molecular Weight | 461.62 |
| AlogP | 4.4 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 10.0 |
| Polar Surface Area | 76.07 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 32.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group F
Nuclear hormone receptor subfamily 1 group F member 3
|
- | 3-20 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Psoriasis | 1 | D011565 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4225088 |
| DrugBank | DB16319 |
| FDA SRS | L49V5G013I |
| Guide to Pharmacology | 9661 |
| SureChEMBL | SCHEMBL15352875 |
| ZINC | ZINC000142250256 |